Clorox (NYSE:CLX) Issues Earnings Results, Beats Estimates By $0.16 EPS

Clorox (NYSE:CLX) issued its earnings results on Monday. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16, RTT News reports. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period in the previous year, the firm posted $2.16 EPS. Clorox updated its FY 2025 guidance to 6.950-7.350 EPS.

Clorox Stock Down 7.2 %

Shares of Clorox stock opened at $148.29 on Wednesday. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a market cap of $18.36 billion, a price-to-earnings ratio of 51.67, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company’s 50 day moving average is $162.63 and its 200 day moving average is $158.67.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. Clorox’s dividend payout ratio is presently 170.04%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CLX. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Wells Fargo & Company boosted their price objective on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Finally, Barclays decreased their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $157.64.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.